Brooks Automation Reports Completion Of Corporate Name Change To 'Azenta,' Ticker Change To 'AZTA'

12/1/21 8:22:07 AM ET

Industrial Machinery/Components

Technology

Get the next $BRKS alert in real time by email

Azenta, Inc. (NASDAQ:AZTA) ("Azenta" or the "Company") announced today that it has completed its previously announced corporate name change from "Brooks Automation, Inc." to "Azenta, Inc." In conjunction with the corporate name change, the Company will begin trading on the Nasdaq Global Select Market under the new ticker symbol, AZTA, effective at the open of market trading on December 1, 2021.

This change follows the launch of the Company's life sciences brand, Azenta Life Sciences and the Investor Day held on November 16, 2021. The Company anticipates completion of the sale of the semiconductor automation business in the first half of calendar year 2022, at which time the Company will become a pure play life sciences company.

Get the next $BRKS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$BRKS

Date	Price Target	Rating	Analyst
11/17/2021	$139.00 → $155.00	Buy	Needham
11/17/2021	$146.00 → $132.00	Overweight	Keybanc
11/11/2021	$100.00 → $120.00	Neutral	Citigroup
11/10/2021	$121.00 → $139.00	Buy	Needham
9/7/2021	$115.00 → $146.00	Overweight	Keybanc
8/6/2021	$130.00 → $114.00	Buy	Needham

More analyst ratings

Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:3
11/7/22 4:38:00 PM ET
$AZTA
$BRKS
Industrial Machinery/Components
Technology
Azenta Announces Completion of B Medical Systems Acquisition
CHELMSFORD, Mass., Oct. 3, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has closed its previously announced acquisition of B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments to more than 150 countries worldwide. This acquisition complements Azenta's cold chain capabilities, adding differentiated solutions for reliable and traceable transport of temperature-sensitive specimens. B Medical, headquartered in Hosingen, Luxembourg, is one of the leading vaccine cold chain providers serving primarily fast-growing emerging markets, w
10/3/22 4:05:00 PM ET
$AZTA
$BRKS
Industrial Machinery/Components
Technology
Azenta to Participate in the Baird 2022 Global Healthcare Conference
CHELMSFORD, Mass., Sept. 6, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in the Baird 2022 Global Healthcare Conference in New York City, on Wednesday, September 14, 2022, which includes a presentation beginning at 9:40 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. About Azenta Life Sciences Azenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain
9/6/22 4:05:00 PM ET
$AZTA
$BRKS
Industrial Machinery/Components
Technology

$BRKS
Financials

Live finance-specific insights

Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast
CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time. To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events. A replay will be available beginning at 8:3
11/7/22 4:38:00 PM ET
$AZTA
$BRKS
Industrial Machinery/Components
Technology
Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022
CHELMSFORD, Mass., Aug. 9, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the third quarter ended June 30, 2022. Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Change 2022 2022 2021 Prior Qtr. Prior Yr. Revenue from Continuing Operations $ 133 $ 146 $ 129 (9) % 3 % Life Sciences Products $ 47 $ 54 $ 49 (12) % (3) % Life Sciences Services $ 85 $ 92 $ 80 (7) % 6 % Diluted EPS Continuing Operations $ (0.09) $ (0.02) $ (0.02) nm nm Diluted EPS Total $ (0.13) $ 28.28 $ 0.53 nm nm Non-GAAP Diluted EPS Continuing Operations $ 0.12 $ 0.12 $ 0.10 0 % 14 % Adjusted EBITDA Continuing Operations $ 14 $ 19 $ 19 (29) % (26) % M
8/9/22 4:20:00 PM ET
$AZTA
$BRKS
Industrial Machinery/Components
Technology
Azenta Announces Agreement to Acquire B Medical Systems
Enhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management CHELMSFORD, Mass., Aug. 8, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to be paid at closing will be approximately €410 million. Additional cash consideration, up to €50 million, may be paid upon achievement of certain future performance milestones. The transaction is expected to close in O
8/8/22 4:05:00 PM ET
$AZTA
$BRKS
Industrial Machinery/Components
Technology